Enterprise Service Level Agreement

Global Drug Intelligence Database

Enterprise SLA & Service Coverage

Enterprise License Pricing

Starting from USD 150,000

11-month enterprise license

Enterprise Global Drug Intelligence Database licensing starts from USD 150,000 for an 11-month enterprise license.

All enterprise licenses include dedicated account management, experienced pharmaceutical consultant support, and enterprise-grade SLA coverage.

Service Level Agreement Details

Comprehensive SLA covering all aspects of the Global Drug Intelligence Database enterprise license.

📋

Service Scope

The Global Drug Intelligence Database is an enterprise-grade structured pharmaceutical intelligence platform providing comprehensive data on drugs, regulatory approvals, clinical trials, patents, and competitive intelligence across global markets.

Enterprise-grade structured pharmaceutical intelligence database

Designed for commercial, medical affairs, market access, licensing, business development, competitive intelligence, regulatory, and strategy teams

AI-powered search and discovery across all data domains

Advanced analytics and enterprise reporting capabilities

Secure enterprise access with role-based permissions

🌍

Data Coverage

Comprehensive global pharmaceutical data covering all major regulatory jurisdictions and therapeutic areas.

Global Drug Database — comprehensive drug profiles worldwide

FDA Intelligence — US FDA drug approvals, labels, NDC, Orange Book

EMA Intelligence — European Medicines Agency approvals and EPARs

Clinical Trial Intelligence — global clinical trial data from ClinicalTrials.gov and other registries

Drug Pipeline Intelligence — Phase I-IV development tracking

Patent & Exclusivity Intelligence — patent expiry, exclusivity periods, Orange Book patents

Mechanism of Action — drug MoA, pharmacology, and target pathways

Drug Targets — molecular targets, receptor interactions, binding data

Biomarkers — companion diagnostics, predictive biomarkers, safety biomarkers

Therapy Areas — therapeutic classifications, indication mapping, ICD codes

Regulatory Intelligence — global regulatory status across FDA, EMA, MHRA, PMDA, CDSCO, NMPA, Health Canada, TGA, Swissmedic, WHO

Drug Lifecycle Intelligence — from discovery to post-market surveillance

🔄

Update Frequency

The database is continuously updated to ensure the most current and accurate pharmaceutical intelligence.

Real-time FDA data ingestion via openFDA API

Daily sync of drug approval announcements and regulatory updates

Weekly clinical trial data refresh from ClinicalTrials.gov

Bi-weekly patent and exclusivity data updates

Monthly comprehensive data quality reviews and enrichment

Quarterly full database audit and validation

📡

FDA & Regulatory Data Refresh Schedule

Automated ingestion from authoritative regulatory sources ensures timely and accurate regulatory intelligence.

FDA Drug Labels (SPL) — daily refresh from FDA openFDA API

ANDA/NDA Approvals — daily monitoring of FDA approval announcements

NDC Product Directory — weekly synchronization

Orange Book Patents & Exclusivity — bi-weekly updates

FAERS Adverse Events — monthly bulk data ingestion

Drug Recalls — real-time alerts and weekly consolidation

EMA EPARs — weekly refresh from EMA website

MHRA, PMDA, CDSCO, NMPA — monthly regulatory intelligence updates

🤖

AI Enhancement Schedule

AI-powered intelligence enhancements are applied on a regular schedule to enrich and validate data.

AI-powered data matching and enrichment — weekly batch processing

Automated conflict detection between FDA and curated data — flagged for review

Low-confidence match review queue — processed by domain experts

AI-generated drug insights and summaries — monthly generation cycle

Predictive analytics model updates — quarterly recalibration

Natural language search index optimization — continuous

🔒

Security & Confidentiality

Enterprise-grade security measures protect your data and ensure confidentiality across all engagements.

Enterprise-grade encryption for data at rest and in transit

Role-based access control (RBAC) with granular permissions

SSO/SAML integration for enterprise authentication

SOC 2 Type II compliant infrastructure

GDPR and HIPAA compliant data handling

Audit logs for all data access and modifications

Dedicated secure enterprise environment

Data isolation per enterprise client

👤

Dedicated Account Manager

Every enterprise database license includes a dedicated account manager as your primary point of contact.

Dedicated account manager assigned at license commencement

Primary point of contact for all service-related queries

Quarterly business reviews and performance reporting

Service level monitoring and escalation management

License administration and user provisioning

Custom requirement gathering and prioritization

🧑‍🔬

Dedicated Consultant

An experienced pharmaceutical consultant is assigned to support your strategic use of the database.

Experienced pharmaceutical consultant with domain expertise

Strategic guidance on database utilization and intelligence interpretation

Custom research and analysis support

Data interpretation and insight generation assistance

Therapy area and competitive intelligence advisory

Monthly strategy sessions to align intelligence with business objectives

🛟

Enterprise Support

Comprehensive enterprise support ensures maximum uptime and rapid issue resolution.

Priority email support with 4-hour response SLA (business hours)

24/7 critical issue monitoring and alerts

Enterprise Service Level Agreement (SLA) with 99.9% uptime target

Dedicated support channel for enterprise clients

Product updates and enhancement notifications

Strategic advisory sessions included

On-demand training sessions for new users

🚀

Onboarding Process

Structured enterprise onboarding ensures your team is productive from day one.

Week 1: Enterprise environment setup and SSO configuration

Week 2: User provisioning and role-based access configuration

Week 3: Platform training sessions for key users and administrators

Week 4: Data familiarization workshop and custom use case mapping

Week 5: Go-live with dedicated consultant and account manager support

Ongoing: Monthly check-ins and quarterly business reviews

📊

Quarterly Reviews

Regular quarterly business reviews ensure continuous alignment with your strategic objectives.

Quarterly Business Review (QBR) with executive stakeholders

Usage analytics and adoption metrics review

Data quality and coverage assessment

Roadmap discussion for upcoming features and data expansions

Strategic alignment session to map intelligence to business priorities

Performance against SLA targets and service improvement plans

Action items and follow-up tracking

Authoritative Data Sources

Our database aggregates and structures data from the most authoritative pharmaceutical and regulatory sources globally.

US FDA (openFDA)

EMA

ClinicalTrials.gov

Orange Book

NDC Directory

FAERS

MHRA

PMDA

CDSCO

NMPA

Health Canada

TGA

Swissmedic

WHO

PatentsView

Frequently Asked Questions

The enterprise license is for 11 months, starting from the license commencement date. Renewal options are available for continued access.

Ready to Access the Global Drug Intelligence Database?

Enterprise Global Drug Intelligence Database licensing starts from USD 150,000 for an 11-month enterprise license. Contact our team to discuss your enterprise requirements.

Contact Sales